Refresh

WOCKHARDT LTD. - Announcement under Regulation 30 (LODR)-Press Release / Media Release


Download
28 Jun 2024
Wockhardt Limited has informed regarding the press release dated June 28, 2024 titled "Globally renowned US body Clinical & Laboratory Standard Institute (CLSI) awards high susceptibility breakpoints to Zaynich (Zidebactam/Cefepime-WCK 5222)".

Source: BSE India

View all announcements for WOCKHARDT LTD.
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com